|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
1477
|
(R)-(-)-Norapomorphine hydrobromide
|
1477.0002: 2 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [11C]-(-)-NPA and [11C]-(-)-NMA
[11C]-(-)-N-Propyl-norapomorphine and
[11C]-(-)-N-Methyl-norapomorphine
|
|
|
|
|
|
Photosensitive
|
|
|
Molar Mass: 334.21
|
|
|
C16H15NO2 ⋅ HBr
|
|
|
[115017-61-3]
|
|
|
(R)-(-)-Norapomorphine free base: [478-76-2]
|
|
|
Colourless to yellowish solid packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H NMR spectra
|
|
|
Chemical Name:
CA index name: 4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-, hydrobromide, (6aR)-
|
|
|
Synonymes:
4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-, hydrobromide, (R)-; R-(-)-Norapomorphine hydrobromide; R-(-)-Norapomorphine ⋅ HBr
|
|
|
Literature:
1. Hwang D.-R. et al. (-)-N-[11C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D2 receptors. Nucl. Med. Biol. 2000, 27, 533-539.
|
|
|
2. Narendran R. et al. In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride. Synapse 2004, 52, 188-208.
|
|
|
3. Zijlstra S. et al. Synthesis and in vivo distribution in the rat of a dopamine agonist: N-([11C]methyl)norapomorphine. Nucl. Med. Biol. 1993, 20, 7-12.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|